CURB-65 — Βαρύτητα κοινοτικής πνευμονίας
Εκτίμηση βαρύτητας κοινοτικής πνευμονίας και απόφαση νοσηλείας — κλίμακα CURB-65 βάσει BTS
Likely suitable for home treatment
Low mortality (1.5%)
NaN
Επιπλέον πληροφορίες
Προειδοποίηση
Αυτό το εργαλείο προορίζεται μόνο για εκπαιδευτικούς σκοπούς, δεν αντιπροσωπεύει και δεν αντικαθιστά επαγγελματικές συμβουλές. Αυτό το εργαλείο δεν πρέπει να χρησιμοποιείται για την παροχή ιατρικών διαγνώσεων ή/και ιατρικών θεραπειών.
General description
CURB-65/CRB-65 estimates mortality of community-acquired pneumonia to help determine inpatient versus outpatient treatment. Based on the score the patients are stratified into three groups with different estimated 30 day mortality: Low mortality, Intermediate mortality, and High mortality.
CURB-65/CRB-65 estimates mortality of community-acquired pneumonia to help determine inpatient versus outpatient treatment. Based on the score the patients are stratified into three groups with different estimated 30 day mortality: Low mortality, Intermediate mortality, and High mortality.
Result ranges
Likely suitable for home treatment
0–1Consider hospital supervised treatment
2Manage in hospital as severe pneumonia
≥ 3Result ranges for CRB-65
Likely suitable for home treatment
0Consider hospital supervised treatment
1–2Manage in hospital as severe pneumonia
≥ 3References
W Lim, M M van der Eerden, R Laing, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May; 58(5): 377–382.
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 2007; 44:S27–72.
Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Disease. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011;17(6):E1–E59.
Έκδοση
2
Σχετικά με αυτό το εργαλείο
CURB-65 estimates mortality of community-acquired pneumonia to help determine inpatient versus outpatient treatment. Based on the score the patients are stratified into three groups with different estimated 30 day mortality: Low mortality (1,5 %), Intermediate mortality (9,2%), and High mortality (22%).
